Ocular-hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: a 6-month follow-up study-Reference-Cited by-同舟云学术

Ocular-hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: a 6-month follow-up study

Published:2004-05-28 Issue:6 Volume:19 Page:625-630
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Chan C K M,Fan D S P,Chan Wai-man,Lai W W,Lee V Y W,Lam D S C

Publisher

Springer Science and Business Media LLC

Subject

General Arts and Humanities,Ophthalmology,Sensory Systems

Link

http://www.nature.com/articles/6701585.pdf

Reference28 articles.

1. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109: 920–927.

2. Jonas JB, Kreissig I, Sofker A, Degenring RF . Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003; 121: 57–61.

3. Spaide RF, Sorenson J, Maranan L . Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2003; 110: 1517–1525.

4. Park CH, Jaffe GJ, Fekrat S . Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003; 136: 419–425.

5. Young S, Larkin G, Branley M, Lightman S . Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol 2001; 29: 2–6.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems;Pharmaceutics;2023-03-29

2. Comparative Outcomes of Standard Perioperative Eye Drops, Intravitreal Triamcinolone Acetonide-Moxifloxacin, and Intracameral Dexamethasone-Moxifloxacin-Ketorolac in Cataract Surgery;Journal of Ophthalmology;2022-07-19

3. Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration;Pharmaceutics;2021-09-17

4. Intraoperative intravitreal triamcinolone acetonide injection for prevention of postoperative inflammation and complications after phacoemulsification in patients with uveitic cataract;BMC Ophthalmology;2021-06-04

5. Safety and Tolerability of Topical Ophthalmic Triamcinolone Acetonide-Loaded Liposomes Formulation and Evaluation of Its Biologic Activity in Patients with Diabetic Macular Edema;Pharmaceutics;2021-03-02